Search results for "topoi"

showing 10 items of 701 documents

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

2017

Abstract The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) in adults, published in 2010, has found broad acceptance by physicians and investigators caring for patients with AML. Recent advances, for example, in the discovery of the genomic landscape of the disease, in the development of assays for genetic testing and for detecting minimal residual disease (MRD), as well as in the development of novel antileukemic agents, prompted an international panel to provide updated evidence- and expert opinion-based recommendations. The recommendations include a revised version of the ELN genetic categories, a proposal for …

PathologyNeoplasm ResidualInternational CooperationDiseaseReview ArticleBiochemistryEuropean LeukemiaNet0302 clinical medicineRisk Factorshemic and lymphatic diseasesCONVENTIONAL CARE REGIMENSDisease management (health)medicine.diagnostic_testACUTE MYELOGENOUS LEUKEMIAHematopoietic Stem Cell TransplantationDisease ManagementSINGLE CEBPA MUTATIONSHematology1ST COMPLETE REMISSIONHIGH-DOSE CYTARABINELeukemia Myeloid AcuteTreatment Outcome030220 oncology & carcinogenesisPractice Guidelines as TopicAdultmedicine.medical_specialtyConsensusImmunologyBUSULFAN PLUS CYCLOPHOSPHAMIDEMEDLINEMINIMAL RESIDUAL DISEASEAntineoplastic AgentsACUTE MYELOID-LEUKEMIAEnasidenibTransplantation AutologousDrug Administration ScheduleImmunophenotyping03 medical and health sciencesmedicineHumansGenetic TestingIntensive care medicineGenetic testingbusiness.industrySTEM-CELL TRANSPLANTATIONCell BiologyRANDOMIZED PHASE-IIIMinimal residual diseaseTransplantationbusinessSettore MED/15 - Malattie del Sangue030215 immunology
researchProduct

Correlation between CD117+ myeloma plasma cells and hematopoietic progenitor cells in different categories of patients

2015

Background Multiple myeloma (MM) is a neoplastic disorder of plasma cells interesting mainly the elderly. MM remains an incurable disease, mostly because of the strong interplay between clonal plasma cells (cPCs) and bone marrow (BM) microenvironment. Multiparameter flow cytometry (MFC) allows the simultaneous study of the cPC immunophenotype and alterations involving other cells in BM, but rarely these data are interpreted as connected. One exception to this habit are previous studies about relationship between CD117 cPC positivity and hematopoietic progenitor cell (HPC) distribution in newly diagnosed patients. Thus we were interested in verifying the distribution of BM CD34+ HPCs in heal…

Pathologymedicine.medical_specialtyAgingImmunologyCD34CD117ImmunophenotypingCD117; Flow cytometry; Hematopoietic progenitor cell; MGUS; Multiple myeloma; Immunology; AgingMultiple myelomamedicineHematopoietic progenitor cellFlow cytometryMultiple myelomaSettore MED/04 - Patologia GeneralebiologyCD117business.industryResearchmedicine.diseasedigestive system diseasesAgeingmedicine.anatomical_structurebiology.proteinMGUSBone marrowAntibodybusinessProgressive diseaseMonoclonal gammopathy of undetermined significance
researchProduct

Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts.

2010

Background Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controversial, and no specific information is available on the effect of BM-MSC on NHL. Methodology/Principal Findings The effect of BM-MSC was analyzed in two in vivo models of disseminated non-Hodgkin's lymphomas with an indolent (EBV− Burkitt-type BJAB, median survival = 46 days) and an aggressive (EBV+ B lymphoblastoid SKW6.4, median survival = 27 days) behavior in nude-SCID mice. Intra-peritoneal (i.p.) i…

Pathologymedicine.medical_specialtyStromal cellTransplantation HeterologousMice Nudelcsh:Medicinemesenchimal stem cellsMice SCIDMiceimmune system diseaseshemic and lymphatic diseasesmesenchymal stem cells non-Hodgkin's lymphoma.AnimalsHumansMedicinehuman lymphoma xenograft; mesenchimal stem cellsOncology/Hematological Malignancieslcsh:ScienceSCID MiceMultidisciplinaryHematology/Bone Marrow and Stem Cell Transplantationbusiness.industryLymphoma Non-HodgkinLymphoblastlcsh:RMesenchymal stem cellNon-Hodgkin's LymphomaMesenchymal Stem CellsHematopoietic Stem Cellsmedicine.diseaseCoculture TechniquesLymphomaNon-Hodgkin's lymphomaEndothelial stem cellTransplantationApoptosislcsh:QHematology/Lymphomas and Chronic Lymphoblastic LeukemiabusinessMesenchymal Stem Cells; SCID Mice; Non-Hodgkin's LymphomaResearch Articlehuman lymphoma xenograft
researchProduct

The “mode” of lymphocyte extravasation through HEV of Peyer's patches and its role in normal homing and inflammation

2007

The mode of lymphocyte transendothelial migration in the postcapillary high endothelial venules (HEVs) of Peyer's patches during normal homing and acute inflammation in the guinea pig was studied. It is common opinion that the lymphocyte transendothelial passage from the blood stream into the extravasal lymphoid tissue calls for a multistep process of endothelial and lymphocyte molecules favoring tethering, rolling, activation, arrest and its firm adhesion to the endothelial luminal surface. Ultrastructural serial pictures and the three-dimensional reconstruction of HEVs with lymphocytes during different moments of their transmigration through the endothelial wall enabled us to demonstrate …

Pathologymedicine.medical_specialtyTime FactorsLymphocyteHigh endothelial venulesGuinea PigsHomingLeukocyte RollingBiologyBiochemistryHigh endothelial venulePeyer's PatchesMicroscopy Electron TransmissionmedicineAnimalsReplica TechniquesLeukocyte RollingLymphocytesLymphocyte homing receptorTransendothelial migrationLymphatic VesselsInflammationICAM-1Endothelial CellsCell BiologyExtravasationEnteritisPeyer PatchChemotaxis LeukocyteDisease Models Animalmedicine.anatomical_structureIntercellular JunctionsPeyer patcheLymphocyteDairy ProductsCardiology and Cardiovascular MedicineExtravasationHoming (hematopoietic)
researchProduct

Tracking of Autologous VSOP-Labeled Mesenchymal Stem Cells in the Sheep Brain Using 3.0 T MRI

2012

Assessment of biodistribution and monitoring of cell migration processes in vivo are essential for the safety of novel cell-based therapies for ischemic stroke and early-stage clinical trials, but are mainly lacking investigation in large animal models which are closer to the situation found in human patients. This chapter reports a series of experiments which establish a MRI-sensitive labeling procedure for autologous ovine mesenchymal stem cells (MSC) and the assessment of in vivo and in vitro detection limits of the cells at 3.0 T. Cell migration was monitored after intravenous transplantation following experimental stroke in sheep. Cell detection was feasible at 3.0 T with detection lim…

Pathologymedicine.medical_specialtybusiness.industryCellMesenchymal stem cellCell migrationIn vitroTransplantationmedicine.anatomical_structureIn vivoParenchymaMedicinebusinessHoming (hematopoietic)
researchProduct

Unexpected postmortem diagnosis of Acanthamoeba meningoencephalitis following allogeneic peripheral blood stem cell transplantation.

2008

Meningoencephalitis caused by pathogenic free-living amebas is usually fatal. Only a few cases of Acanthamoeba meningoencephalitis, diagnosed at autopsy, have been reported following hematopoietic stem cell transplantation. We here report a case of Acanthamoeba meningoencephalitis following allogeneic peripheral blood stem cell transplantation with rapidly evolving neurologic symptoms that remained unexplained. Magnetic resonance imaging failed to show brain lesions and cerebrospinal fluid was negative for microbiological cultures. Definite diagnosis was an unexpected autopsy finding. As overall and teaching hospital autopsy rates are declining worldwide, we must emphasize the need of autop…

Pathologymedicine.medical_specialtymedicine.medical_treatmentAcanthamoebaAutopsyHematopoietic stem cell transplantationCentral nervous system diseaseCerebrospinal fluidMeningoencephalitismedicineAnimalsHumansImmunology and AllergyPharmacology (medical)Postmortem DiagnosisPeripheral Blood Stem Cell TransplantationTransplantationbiologybusiness.industryMeningoencephalitisAmebiasismedicine.diseasebiology.organism_classificationAcanthamoebaStem cellbusiness
researchProduct

Hepatic progenitors for liver disease: current position

2010

Alice Conigliaro1, David A Brenner2, Tatiana Kisseleva21University “La Sapienza”, Dipartimento di Biotecnologie Cellulari ed Ematologia Policlinico Umberto I, V Clinica Medica, Rome, Italy; 2Department of Medicine, University of California, San Diego, La Jolla, CA, USAAbstract: Liver regeneration restores the original functionality of hepatocytes and cholangiocytes in response to injury. It is regulated on several levels, with different cellular populations contributing to this process, eg, hepatocytes, liver precursor cells, intrahepatic stem cells. In response to injury, mature hepatocytes have the capability to proliferate and give rise to new hepatocytes and cholangi…

Pathologymedicine.medical_specialtyoval cellsLiver cytologyMedicine (miscellaneous)cholangiocytes; hepatic progenitor; hepatocytes; intrahepatic stem cells; liver disease; liver precursor cells; oval cellsReviewBiologyhepatocytemedicinecholangiocytesProgenitor cellliver precursor cellQH573-671Mesenchymal stem cellintrahepatic stem cellCell Biologyhepatic progenitorliver precursor cellsintrahepatic stem cellsLiver regenerationCell biologyHaematopoiesisAmniotic epithelial cellsHepatic stellate cellhepatocytesStem cellCytologyliver diseasecholangiocyteStem Cells and Cloning: Advances and Applications
researchProduct

In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues.

2021

Abstract In vivo phage display is widely used for identification of organ- or disease-specific homing peptides. However, the current in vivo phage biopanning approaches fail to assess biodistribution of specific peptide phages across tissues during the screen, thus necessitating laborious and time-consuming post-screening validation studies on individual peptide phages. Here, we adopted bioinformatics tools used for RNA sequencing for analysis of high-throughput sequencing (HTS) data to estimate the representation of individual peptides during biopanning in vivo. The data from in vivo phage screen were analyzed using differential binding—relative representation of each peptide in the target…

Phage displayT7 phageAcademicSubjects/SCI00010virusesPeptideBiopanningComputational biologyDeep sequencing03 medical and health sciencesMiceIn vivoPeptide LibraryGeneticsAnimalsTissue DistributionMolecular Biology030304 developmental biologychemistry.chemical_classification0303 health sciencesMice Inbred BALB Cbiology030302 biochemistry & molecular biologyRNAHigh-Throughput Nucleotide Sequencingbiology.organism_classificationHigh-Throughput Screening AssayschemistryCell Surface Display TechniquesPeptidesHoming (hematopoietic)Nucleic acids research
researchProduct

Generation of human hepatocytes by stem cell technology: definition of the hepatocyte

2006

Since 1999, numerous articles have reported the generation of hepatocytes from different types of extrahepatic stem or precursor cells. This opens exciting new possibilities for pharmacology and toxicology, as well as for cell therapy. Hepatocyte marker expression, including albumin, cytokeratin 18, c-met, alpha-fetoprotein and cytochrome P450 3A4 and -2B6, has been observed after transplantation of different types of human stem cells into the liver of laboratory animals or in vitro after incubation with cytokines. These intriguing observations have prompted scientists to classify stem cell-derived cell populations as hepatocytes. However, this conclusion may be premature. It has been shown…

PharmacologyCellular differentiationTransdifferentiationBiomedical TechnologyHematopoietic Stem Cell TransplantationCell DifferentiationGeneral MedicineBiologyHematopoietic Stem CellsToxicologyCell biologyEndothelial stem cellTransplantationCell therapyCancer stem cellHepatocytesAnimalsHumansStem cellAdult stem cellExpert Opinion on Drug Metabolism & Toxicology
researchProduct

In vivo stimulation of murine haematopoiesis by the antineoplastic agent bryostatin-1

1990

PharmacologyDrugDose-Response Relationship DrugBryostatin 1ChemistryInjections Subcutaneousmedia_common.quotation_subjectMice Inbred StrainsStimulationPharmacologyBryostatinsHematopoietic Stem CellsAntineoplastic Agents PhytogenicHematopoiesisLactonesMiceBryostatinsHaematopoiesisDose–response relationshipInbred strainIn vivoAnimalsFemaleMacrolidesmedia_commonPharmacological Research
researchProduct